Abbonarsi

Relationship of ejection fraction and natriuretic peptide trajectories in heart failure with baseline reduced and mid-range ejection fraction - 26/11/21

Doi : 10.1016/j.ahj.2021.08.015 
Kenneth C. Bilchick, MD, MS a, , Patrick Stafford, MD a, Olusola Laja, MD a, Comfort Elumogo, MD a, Persey Bediako, MD a, Nora Tolbert, MD a, Douglas Sawch, MD a, Sthuthi David, MD, MS a, Nishtha Sodhi, MD a, Anita Barber, BS a, Younghoon Kwon, MD b, Nishaki Mehta, MD c, Brandy Patterson, MD a, Khadijah Breathett, MD, MS d, Sula Mazimba, MD, MPH a
a Department of Medicine, University of Virginia Health System, Charlottesville, Virginia 
b Division of Cardiology, University of Washington, Seattle, Washington 
c Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan 
d Division of Cardiology, Department of Medicine, Sarver Heart Center, University of Arizona, Tucson 

Reprint requests: Kenneth Bilchick, MD, MS, UVA Health System, Cardiovascular Division, P.O. Box 800158, Charlottesville, VA 22908.UVA Health System, Cardiovascular DivisionP.O. Box 800158CharlottesvilleVA22908

Abstract

Background

The prognostic importance of trajectories of neurohormones relative to left ventricular function over time in heart failure with reduced and mid-range EF (HFrEF and HFmrEF) is poorly defined.

Objective

To evaluate left ventricular ejection fraction (LVEF) and B-type natriuretic peptide (BNP) trajectories in HFrEF and HFmrEF.

Methods

Analyses of LVEF and BNP trajectories after incident HF admissions presenting with abnormal LV systolic function were performed using 3 methods: a Cox proportional hazards model with time-varying covariates, a dual longitudinal-survival model with shared random effects, and an unsupervised analysis to capture 3 discrete trajectories for each parameter.

Results

Among 1,158 patients (68.9 ± 13.0 years, 53.3% female), both time-varying LVEF measurements (P=.001) and log-transformed BNP measurements (p-values=2 × 10−16) were independently associated with survival during 6 years after covariate adjustment. In the dual longitudinal/survival model, both LVEF and BNP trajectories again were independently associated with survival (P<.0001 in each model); however, LVEF was more dynamic than BNP (P <.0001 for time covariate in LVEF longitudinal model versus P=.88 for the time covariate in BNP longitudinal model). In the unsupervised analysis, 3 discrete LVEF trajectories (dividing the cohort into approximately thirds) and 3 discrete BNP trajectories were identified. Discrete LVEF and BNP trajectories had independent prognostic value in Kaplan-Meier analyses (P<.0001), and substantial membership variability across BNP and LVEF trajectories was noted.

Conclusion

Although LVEF trajectories have greater temporal variation, BNP trajectories provide additive prognostication and an even stronger association with survival times in heart failure patients with abnormal LV systolic function.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract

Dual Trajectory Analysis for Prognosis in Heart Failure. Trajectory analyses based on the survival model with time-varying covariates and the dual longitudinal-survival model with shared random effects were performed, then an unsupervised analysis based on discrete trajectories was performed. The 3 discrete LVEF trajectories, the 3 BNP trajectories, and their associations with prognosis are shown.



Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ACE inhibitor, ARB, ARNI, BB, BNP, BUN, COPD, HF, HFmrEF, HFpEF, HFrEF, LVEF, NT-proBNP


Mappa


© 2021  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 243

P. 1-10 - Gennaio 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety
  • Jonathan Seltzer, Fortunato Senatore, Ken Faulkner, Kenneth Martin Stein, Lt Stephen Browning, Polina Voloshko, Elektra J. Papadopoulos
| Articolo seguente Articolo seguente
  • Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program
  • Jorge Plutzky, Mark D. Benson, Kira Chaney, Tiffany V. Bui, Michael Kraft, Lina Matta, Marian McPartlin, David Zelle, Christopher P. Cannon, Anton Dodek, Thomas A. Gaziano, Akshay S. Desai, Calum A. MacRae, Benjamin M. Scirica

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.